Clinical Tool

Rating Scale Comparison

Rating Scale Comparison

Quick Reference Tool | PsychHQ Source: Module 2, Assessment & Differential Diagnosis | Last Updated: February 2026


Foundational Principles

Rating scales are one component of a comprehensive ADHD evaluation — they are not the evaluation itself. No single rating scale, used in isolation, should be the basis for confirming or ruling out ADHD. (Pelham et al., 2005, J Clin Child Adolesc Psychol)

Think of rating scales like a thermometer: a high reading tells you something is going on and you need to look further, but it does not tell you exactly what is causing the fever. A high score on an ADHD rating scale means the next step is a full evaluation, not that the diagnosis is settled.


Head-to-Head Comparison Table

Feature Vanderbilt (VADRS) Conners 4 SNAP-IV BRIEF-2 CBCL ASRS
Ages 6–12 6–18 6–18 5–18 1.5–18 Adults (18+)
Cost Free Licensed (per-use) Free Licensed Licensed Free
Items 55 (Parent), 43 (Teacher) Up to 118 (Full), ~50 (Short), 12 (Index) 26 63 (Parent/Teacher), 55 (Self-Report) 113 (Parent), 120 (Teacher) 18 (Full), 6 (Screener)
Informants Parent + Teacher Parent + Teacher + Youth Self-Report (8–18) Parent + Teacher Parent + Teacher + Self-Report (11–18) Parent + Teacher Self-Report
ADHD symptom coverage DSM-mapped inattention + hyperactivity-impulsivity Inattention/Executive Dysfunction, Hyperactivity, Impulsivity subscales with age/sex-normed T-scores Direct DSM symptom wording (18 ADHD + 8 ODD items) Not an ADHD diagnostic tool; measures executive function Attention Problems scale (not ADHD-specific) DSM-mapped ADHD symptoms
Comorbidity screening ODD, conduct disorder, anxiety, depression Emotional Dysregulation, Depressed Mood, Anxious Thoughts, severe indicator items (self-harm, substance use) ODD only N/A (EF profile, not diagnostic) Comprehensive: internalizing, externalizing, DSM-oriented N/A
Performance/impairment items Yes (academic + social) Yes (dedicated Impairment + Functional Outcome Scales) No Yes (ecological EF) Yes No
Sensitivity ~0.80 ~0.83 (ADHD Index at T≥65) Good (research standard) N/A N/A High
Specificity ~0.75 ~0.85 (ADHD Index at T≥65) Good N/A N/A Low in general population
NPV (negative predictive value) 0.98 (reliably rules out) High Good N/A N/A High
PPV (positive predictive value) 0.19 (most positives are false) Higher than Vanderbilt Moderate N/A N/A Very low (~10% true positives in general screening)
Treatment monitoring Yes (follow-up forms with side effect tracking) Yes (short form) Yes (primary use case) Yes (track EF changes) Not ideal (too long for repeated use) Yes
Best use case Primary care screening; treatment monitoring; free, fast, validated Comprehensive clinical evaluation; broadest clinical coverage; multi-dimensional profile Treatment monitoring; research; DSM symptom tracking Executive function profiling; intervention planning Broad psychopathology screening; detecting comorbidities Adult ADHD screening (not diagnosis)

Instrument-by-Instrument Clinical Guide

Vanderbilt ADHD Diagnostic Rating Scale (VADRS)

Reach for this when: You need a quick, free, validated screen in a busy pediatric practice. Also ideal for treatment monitoring since the follow-up forms include medication side effect tracking.

Psychometric highlights:

  • Internal consistency: Cronbach's α 0.91–0.94 across subscales
  • Test-retest reliability: >0.80 over two weeks
  • NPV of 0.98: a negative Vanderbilt reliably rules out ADHD
  • PPV of only 0.19: out of every 100 children who score positive, only ~19 actually have ADHD. This is not a flaw — it reflects the mathematics of screening in populations where the base rate is relatively low

Key limitation: Weak for detecting internalizing comorbidities (sensitivity ~0.37 for anxiety/depression modules). If you suspect internalizing comorbidity, supplement with a broadband measure — a scale that screens across many diagnostic categories rather than just ADHD (CBCL or Conners 4).

Age range limitation: Validated for ages 6–12 only. For adolescents, use Conners 4 or SNAP-IV.

(Wolraich et al., 2003, Pediatrics; Bard et al., 2013, J Dev Behav Pediatr)


Conners 4th Edition (Conners 4)

Reach for this when: You need the most comprehensive clinical picture — age/sex-normed T-scores, multi-dimensional symptom profile, and comorbidity screening all in one instrument.

What the 4th Edition adds:

  • Modern normative data (2022 standardization)
  • Digital administration option
  • Emotional Dysregulation scale (captures the "hot" executive function deficits)
  • Severe indicator items flagging conduct problems, self-harm risk, and substance use (immediate safety alerts)
  • Dedicated Impairment and Functional Outcome Scales

T-score interpretation:

  • 50 = average; each 10 points = one standard deviation
  • T ≥ 65 = top ~7% for symptom severity compared to same-age, same-sex peers
  • ADHD Index at T ≥ 65: sensitivity ~0.83, specificity ~0.85

Note: Psychometric data are from the publisher's standardization sample. Independent validation in community samples may yield different performance.

Key limitation: Per-use licensing cost. For high-volume primary care screening, the free Vanderbilt may be more practical.

(Conners, 2022)


SNAP-IV (Swanson, Nolan, and Pelham-IV)

Reach for this when: You need to track treatment response over time using direct DSM symptom wording. This is the scale the landmark MTA study used.

Clinical strengths:

  • Direct translation of DSM criteria into a rating format (exact symptom wording)
  • 26 items: 18 ADHD symptoms + 8 ODD symptoms, rated 0–3
  • Free and fast
  • Ideal for measuring medication response at each titration step

Key limitation: Uses DSM wording rather than behaviorally anchored descriptions, making it somewhat less informative than the Conners or Vanderbilt for initial evaluation. Does not include impairment/performance items.

(Swanson et al., 2001, Educ Psychol Meas)


BRIEF-2 (Behavior Rating Inventory of Executive Function, 2nd Edition)

Reach for this when: You need to map the executive function profile for intervention planning — particularly when standard neuropsych testing shows no deficit but the child is clearly struggling in daily life.

Why it matters: Roughly 50% of children with confirmed ADHD show no deficit on standard neuropsych batteries (Coghill, Seth & Matthews, 2014, Psychol Med). The BRIEF-2 captures the real-world expression of executive dysfunction — the kid who cannot organize their backpack, start homework independently, or shift between tasks, even when they perform fine in a structured testing room.

Yields:

  • Global Executive Composite (overall EF score)
  • Behavioral Regulation Index (impulse control, self-monitoring)
  • Emotion Regulation Index (managing emotional responses)
  • Cognitive Regulation Index (working memory, planning, mental flexibility)

Clinical application: If a child's BRIEF-2 shows elevated Working Memory and Plan/Organize indices but normal Inhibit and Shift indices, that tells you something different about their intervention needs than the reverse pattern.

Key limitation: Not a diagnostic instrument for ADHD. Supplemental to ADHD-specific scales.

(Gioia et al., 2015)


Child Behavior Checklist (CBCL)

Reach for this when: You need to screen broadly for psychopathology beyond ADHD — especially when internalizing comorbidities (anxiety, depression, somatic complaints) are suspected.

Structure:

  • Parent form: ages 6–18; Preschool version: ages 1.5–5
  • Internalizing composite (anxiety, depression, withdrawal)
  • Externalizing composite (aggression, defiance, hyperactivity)
  • DSM-oriented scales including Attention Problems

Best used as: The broadband complement to a narrowband ADHD scale. The Vanderbilt or Conners tells you about ADHD severity; the CBCL tells you what else is going on.

Key limitation: Not designed as an ADHD-specific tool. The Attention Problems scale is less precise for ADHD diagnosis than purpose-built instruments.

(Achenbach & Rescorla, 2001)


Adult ADHD Self-Report Scale (ASRS)

Reach for this when: Screening an adult for possible ADHD. The 6-item screener is fast; the 18-item version maps DSM criteria.

Critical limitation: The ASRS is highly sensitive but has low specificity in general populations. Using it as a diagnostic tool rather than a screening prompt can produce a 7-to-10-fold over-identification rate, with roughly 90% of positive screens representing false positives when subjected to comprehensive multi-informant evaluation. (Sibley et al., 2021, Am J Psychiatry)

Bottom line: A positive ASRS means "evaluate further." It does not mean "diagnose ADHD." Adult diagnosis requires retrospective childhood history + collateral informant + comprehensive clinical interview.

(Kessler et al., 2005; Sibley et al., 2021)


Clinical Decision Framework

Clinical Situation Recommended Scale(s)
Primary care screening (ages 6–12) Vanderbilt (free, validated, includes comorbidity screen and follow-up forms)
Comprehensive clinical evaluation Conners 4 (broadest coverage) + CBCL (if internalizing suspected)
Treatment monitoring / titration SNAP-IV (free, DSM-mapped, fast) or Vanderbilt follow-up forms
Executive function profiling BRIEF-2 (especially when neuropsych testing is normal but daily function is impaired)
Adolescent evaluation (13–18) Conners 4 (includes Youth Self-Report) + adolescent self-report
Adult screening ASRS-6 screener → if positive, comprehensive clinical interview with collateral informant
Suspected internalizing comorbidity Add CBCL to any ADHD-specific scale
Research / clinical trials SNAP-IV (MTA standard)
Budget-constrained practice Vanderbilt (screening) + SNAP-IV (monitoring) — both free

When Parent and Teacher Ratings Disagree

Cross-informant agreement for ADHD symptoms is consistently modest (correlations ranging from near zero to ~0.44 on hyperactivity-impulsivity). This is not a measurement failure. Different informants observe different demands:

Informant What They Observe What They May Miss
Parent Unstructured time, emotional regulation, homework, family interactions, weekend behavior Sustained cognitive demands, peer comparison, classroom behavior
Teacher Academic performance, sustained attention demands, peer interactions, classroom behavior Home behavior, emotional regulation outside school, medication wear-off
Adolescent self-report Internal experiences, subjective distress, medication effects, peer context May minimize symptoms (poor insight or desire to appear normal) or maximize (seeking diagnosis)
Collateral informant (adult dx) Childhood behavior, long-term patterns, relationship impact May have recall bias or limited contact

When ratings diverge, the clinical question is not "who is right?" but "what is different about these two environments?" Where is the child scaffolded, and where are they not? A child who scores low on teacher Vanderbilt but high on parent Vanderbilt may have strong classroom structure compensating for deficits that emerge in unstructured home settings — or the reverse.


Psychometric Concepts Translated

Term What It Means Why It Matters
Sensitivity How well the test catches real cases (true positive rate) High sensitivity = few missed cases. Important for screening
Specificity How well the test avoids false alarms (true negative rate) High specificity = few false positives. Important for diagnosis
Positive Predictive Value (PPV) If the test is positive, what is the probability the patient actually has the condition? Depends heavily on the base rate in the population being tested. Low PPV in general screening is expected, not a flaw
Negative Predictive Value (NPV) If the test is negative, what is the probability the patient does NOT have the condition? High NPV = a negative result reliably rules out. Vanderbilt's NPV of 0.98 means a negative screen is very reassuring
T-score Standardized score: 50 = average, each 10 points = one standard deviation Allows comparison to same-age, same-sex peers. T ≥ 65 = top ~7%
Cronbach's alpha Internal consistency — do the items measure the same construct? α > 0.80 = good; α > 0.90 = excellent

This quick reference tool is extracted from Module 2: Assessment & Differential Diagnosis. For full evidence review, sensitivity/specificity data, clinical vignettes, and the complete differential diagnosis framework, see the full clinical module.

For the full clinical curriculum, visit psychhq.com

Key References: Wolraich et al. (2003) Pediatrics; Bard et al. (2013) J Dev Behav Pediatr; Conners (2022); Swanson et al. (2001) Educ Psychol Meas; Gioia et al. (2015); Achenbach & Rescorla (2001); Pelham et al. (2005) J Clin Child Adolesc Psychol; Sibley et al. (2021) Am J Psychiatry; Kessler et al. (2005)